Literature DB >> 16755453

Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report.

H J Ankersmit1, R Ullrich, B Moser, K Hoetzenecker, S Hacker, P German, C Krenn, R Horvat, M Grimm, E Wolner, A Zuckermann.   

Abstract

Giant cell myocarditis (GCM) is a rare and frequently fatal disorder. Patients suffer of ventricular arrhythmias or congestive heart failure. Here we describe a patient with cardiogenic shock and histological verified GCM. The patient was saved by implantation of extracorporeal membrane oxygeneation (ECMO) device and concomitant application of Rabbit antithymocyte globuline (rATG, Thymoglobulin, Sangstat), cyclosporine, and steroids in the acute event. 12 months after the crisis the patient evidences NYHA class I heart function and only a moderate impairment of heart function (EF 55%). The novel utilisation of ECMO in GCM related cardiogenic shock and application of rATG have prooven life-saving in this patient. Studies utilizing rATG in the treatment of GCM are warrented.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16755453     DOI： 10.1055/s-2006-923803

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN： 0171-6425            Impact factor:   1.827


  7 in total

Review 1.  Small steps for idiopathic giant cell myocarditis.

Authors:  Jeffrey A Shih; Jennifer A Shih
Journal:  Curr Heart Fail Rep       Date:  2015-06

2.  Usefulness of immunosuppression for giant cell myocarditis.

Authors:  Leslie T Cooper; Joshua M Hare; Henry D Tazelaar; William D Edwards; Randall C Starling; Mario C Deng; Santosh Menon; G Martin Mullen; Brian Jaski; Kent R Bailey; Madeleine W Cunningham; G William Dec
Journal:  Am J Cardiol       Date:  2008-09-18       Impact factor: 2.778

3.  Giant cell myocarditis with incessant ventricular arrhythmias treated successfully with methylprednisolone and rat antithymocyte globulin.

Authors:  Mudassar Baig; Rob Hatrick
Journal:  Cardiol Res Pract       Date:  2011-04-27       Impact factor: 1.866

4.  A case of a giant cell myocarditis that developed massive left ventricular thrombus during percutaneous cardiopulmonary support.

Authors:  Yusuke Takei; Yutaka Ejima; Hiroaki Toyama; Kana Takei; Takahisa Ota; Masanori Yamauchi
Journal:  JA Clin Rep       Date:  2016-11-29

5.  2019 EACTS Expert Consensus on long-term mechanical circulatory support.

Authors:  Evgenij V Potapov; Christiaan Antonides; Maria G Crespo-Leiro; Alain Combes; Gloria Färber; Margaret M Hannan; Marian Kukucka; Nicolaas de Jonge; Antonio Loforte; Lars H Lund; Paul Mohacsi; Michiel Morshuis; Ivan Netuka; Mustafa Özbaran; Federico Pappalardo; Anna Mara Scandroglio; Martin Schweiger; Steven Tsui; Daniel Zimpfer; Finn Gustafsson
Journal:  Eur J Cardiothorac Surg       Date:  2019-08-01       Impact factor: 4.191

6.  Mononuclear cell secretome protects from experimental autoimmune myocarditis.

Authors:  Konrad Hoetzenecker; Matthias Zimmermann; Wolfram Hoetzenecker; Thomas Schweiger; Dagmar Kollmann; Michael Mildner; Balazs Hegedus; Andreas Mitterbauer; Stefan Hacker; Peter Birner; Christian Gabriel; Mariann Gyöngyösi; Przemyslaw Blyszczuk; Urs Eriksson; Hendrik Jan Ankersmit
Journal:  Eur Heart J       Date:  2013-01-14       Impact factor: 29.983

Review 7.  Peripheral blood mononuclear cell secretome for tissue repair.

Authors:  Lucian Beer; Michael Mildner; Mariann Gyöngyösi; Hendrik Jan Ankersmit
Journal:  Apoptosis       Date:  2016-12       Impact factor: 4.677
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.